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Summary. Obstructive sleep apnea is a disease
characterized by repetitive breathing during sleep that
lead to reduced oxygen saturation and sleep disturbance
among other symptoms. Obstructive sleep apnea is
caused by blockade of the upper respiratory airway,
although the pathogenic mechanism underlying this
occlusion remains unknown. In these studies we
explored the hypothesis that alterations in the
innervation, especially mechanosensory innervation, of
the pharynx may contribute to obstructive sleep apnea.
We tested this hypothesis by analyzing the innervation of
the human pharynx in normal individuals and in subjects
clinically diagnosed with obstructive sleep apnea. Using
immunohistochemistry for axon and Schwann cells, as
well as for two putative mechanoproteins (ASIC2 and
TRPV4), we observed a significant reduction in the
density of nerve fibers in the submucosa of patients with
obstructive sleep apnea as well as morphological
abnormalities in mechanosensory corpuscles.
Importantly, while ASIC2 and TRPV4 expression was
regularly found in the axons of mechanosensory
corpuscles distributed throughout the muscular layer in
the control subjects, it was absent in patients with
obstructive sleep apnea. These findings support that
neurological alterations are important contributors to the
pathogenesis of obstructive sleep apnea.
Key words: Upper airways, Nerve fibres, Mechano-
sensory innervation, Mechanoproteins
Introduction
Airway size and resistance are tightly regulated by
neural mechanisms in the upper airways (UA) that
control muscles and reflexes. The sensory receptors in
the UA respond to changes in airway pressure, airflow
and temperature, as well as muscle tone. These afferent
inputs reach the brainstem respiratory centers, which
control UA muscles via efferent motor neural outputs
(reviewed by Horner, 2012).
Obstructive sleep apnea syndrome (OSAS; Dempsey
et al., 2010) is a common disease that afflicts 2-4% of
the population and has a strong genetic component
(Paiva and Attarian, 2014). Moreover, it is well known
that age, gender, craniofacial structure and the anatomy
of the UA, endocrine condition and obesity, but not
ethnicity, are associated with OSAS (Ralls and Grigg-
Damberger, 2012). 
In recent years multiple studies have demonstrated
altered UA sensory input and abnormal UA motor
function in patients with OSAS using a variety of
neurophysiological and histological approaches
(Guilleminault et al., 2005; Guilleminault and Ramar,
2009; Saboisky et al., 2012a,b). Association between
OSAS and sensory neuropathy outside the UA
(Lüdemann et al., 2001), type 2 or type 1A diabetic
neuropathy, and axonal subtypes of Charcot-Marie-
Tooth disease (Tahrani et al., 2012; Aurora and Punjabi,
2013; Boentert et al., 2013; Fujihara et al., 2013) has
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been also demonstrated. Furthermore, it has been
hypothesized that local nerve lesions due to long-
standing snoring vibrations could be basis of OSAS or
its progression (Friberg et al., 1998; Friberg, 1999;
Svanborg, 2001). Motor neuron lesions and/or direct
damage in the muscles (Friberg et al., 1999; Sunnergren
et al., 2011) are also present in OSAS patients. However,
the changes in muscle fibers (Lindman and Stål, 2002;
Svanborg, 2005; Stål and Johansson, 2012) are not a
major contributing factor to OSAS pathogenesis in most
patients (Eckert et al., 2007). Thus, there is much
evidence that UA neuromuscular abnormalities are
frequent in OSAS patients, and all together support the
“neurogenic theory” of OSAS (see for a review Saboisky
et al., 2012a; Tsai et al., 2013). Consistent with the
above data, studies on the innervation of the palate-
pharyngeal region in OSAS patients have revealed both
increased and decreased number of nerves in the mucosa
and muscles (Friberg et al., 1997; Boyd et al., 2004; De
Bellis et al., 2012), as well as ultrastructural
degenerative changes in myelinated and unmyelinated
nerve fibers (Bassiouny et al., 2009). 
In the present study we explored the hypothesis that
alterations in this mechanosensory innervation may lead
to OSAS by analyzing the innervation of the human
pharynx in subjects clinically diagnosed with OSAS.
The findings support the neurogenic origin paradigm for
OSAS (Guilleminault et al., 2005; Guillaumet and
Ramar, 2009; Levy et al., 2012). 
Materials and methods
Material
The study was carried out using pharynx samples
from autopsies of 10 patients that died due to
pathologies other than those involving upper respiratory
tract or respiratory pathologies. The subjects included in
this study were 3 females (age range 47 to 66 years) and
7 males (age range 52 to 78 years) recruited during a 3
year period in the Surgical Pathology Department,
Asturias Central University Hospital (HUCA), Oviedo,
Spain (Table 1). The subjects selected had been
diagnosed with OSAS for more than 2 years according
to the criteria of the Spanish Society of Respiratory
Pathology (Consensus Document; Puertas Cuesta et al.,
2005). As controls, samples from pharynx were obtained
during removal of organs for transplantation from
subjects that died in traffic incidents (HUCA) from 4
females (age-range 36 to 62 years), and 3 males (age-
range 26 to 60 years) free of known OSAS, UA
pathologies or neurological disease. All materials were
obtained in compliance with Spanish Laws, and the
guidelines of the Helsinki Declaration II. 
From each pharynx the lateral and posterior walls of
the oropharynx and the lateral walls of the hypopharynx
were sampled. The tissue samples consisted of 1-2 cm2
fragments containing the whole thickness of the
pharyngeal walls. The samples were fixed in 10%
formaldehyde in 0.1 M phosphate buffer saline (PBS) at
pH 7.4 for 24 h at 4°C, dehydrated and embedded in
paraffin. Sections 10 μm and 30 μm thick perpendicular
or parallel to the pharynx surface were obtained,
mounted on gelatin-coated microscope slides and
processed for immunohistochemistry. 
Immunohistochemistry
Indirect peroxidase-antiperoxidase immunohisto-
chemistry was performed as follows: sections were
deparaffinized and rehydrated, then rinsed in 0.05 M
HCl Tris buffer (pH 7.5) containing 0.1% bovine serum
albumin and 0.1% Triton X-100. Thereafter the
endogenous peroxidase activity (3% H2O2) and non-specific binding were blocked with 10% fetal calf serum,
and the sections incubated overnight in a humid chamber
at 4°C with primary antibodies (Table 2). The antibody
against NSE was used as specific axon marker;
antibodies against S100 protein were used to
immunolabel Schwann cells and Schwann-related cells
(see Vega et al., 2009). Antibodies against ASIC2 and
TRPV4 were used to detect these two putative
mechanoproteins (Del Valle et al., 2012). After
incubation with the primary antibodies, sections were
2
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Table 1. Data about the OSAS subjects used in these studies.
Case number Age Gender Snoring BMI Associated diseases Cause of death
1 47 F Yes > 30 No CVA
2 52 M Yes > 30 Hypertension CVA
3 53 F Yes > 20 Type 2 diabetes CVA
4 61 M n.d. > 30 Hypertension CVA
5 66 F Yes > 25 No DA
6 68 M Yes > 30 Hypertension CVA
7 72 M Yes > 30 Hypertension CVA
8 76 M Yes > 20 Type II diabetes CVA
9 78 M Yes > 30 Hypertension PC
10 78 M Yes > 20 Hypertension, type II diabetes CVA




rinsed in the same buffer and incubated with Dako
EnVision System labeled polymer-HR anti-rabbit IgG or
anti-mouse IgG (DakoCytomation, Denmark) for 30
minutes at room temperature. Finally, sections were
washed and the immunoreaction visualized using 3-3’-
diaminobenzidine as a chromogen. To ascertain
structural details, sections were slightly counterstained
with hematoxylin & eosin. 
Double immunohistochemistry
Double immunostaining was performed on 10 µm
and 30 µm thick deparaffinized and rehydrated sections.
Non-specific binding was reduced by incubation for 30
minutes with a solution of 1% bovine serum albumin in
TBS. The sections were then incubated overnight at 4°C
in a humid chamber with a 1:1 mixture of anti-NSE and
anti-S100P antibodies; anti-NSE with anti-ASIC2 or
anti-TRPV4 antibodies; anti-S100 with anti-ASIC2 or
anti-TRPV4 antibodies. After rinsing with TBS, the
3
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Fig. 1. Submucous nerves in pharynx control (a) and OSAS patients (b-f) were evidenced using an antibody against the general neuronal marker NSE
(a, b) and the Schwann cell marker S100 protein (c-f). They form isolated nerve fibers, nerve bundles and perivascular plexuses. In some cases
intraepithelial S100 protein positive cells, identified as Langerhans cells, were found. bv, blood vessels; e, epithelium.
Table 2. Primary antibodies used in the study.
Antigen Origin Dilution Supplier
General neural markers
NSE (clone BBS/NC/VI-H14) Mouse 1:1000 Dako1
S-100 protein Rabbit 1:1000 Dako1
S100P (clone 4C4.9) Mouse 1:1000 Thermo Scientific2
Mechanoproteins
ASIC2 Rabbit 1:200 Lifespan Biosciences3
TRPV4 Rabbit 1:100 Abcam4
ASIC2, acid-sensing ion channel 2; NSE, neuron specific enolase;
TRPV4, transient receptor potential channel vanilloid 4; 1Glostrup,
Denmark; 2Thermo Scientific, Freemont, CA, USA; 3Seattle, WA, USA;
4Cambridge, UK. Anti-ASIC2: rabbit polyclonal antibody raised against a
synthetic peptide from the extracellular domain of mouse ASIC2
conjugated to an immunogenic carrier protein. Catalogue LS-C93915.
Blocking peptide: Lifespan Biosciences LS-PB156. Anti-TRPV4: rabbit
polyclonal antibody raised against a synthetic peptide derived from the
cytoplasmic N-terminus domain, which is conserved in mouse, human
and rat TRPV4, conjugated to immunogenic carrier protein. Catalogue




sections were incubated for 1 hour with Alexa fluor 488-
conjugated goat anti-rabbit IgG (Serotec, Oxford, UK),
diluted 1:1000 in TBS containing 5% mouse serum
(Serotec), then rinsed again and incubated for another
hour with Cy™3-conjugated donkey anti-mouse
antibody (Jackson-ImmunoResearch, Baltimore, MD,
USA) diluted 1:50 in TBS. Both steps were performed at
room temperature in a dark humid chamber. Finally, to
ascertain structural details, sections were counterstained
with DAPI (10 ng/ml). Sections were then washed,
dehydrated and mounted with Entellan®. Triple staining
was detected using a Leica DMR-XA automatic
fluorescence microscope coupled with Leica Confocal
Software, version 2.5 (Leica Microsystems, Heidelberg
GmbH, Germany) and the images captured were
processed using the software Image J version 1.43 g
Master Biophotonics Facility, Mac Master University
Ontario (www.macbiophotonics.ca; see also the legend
of supplementary material). 
Controls
To test the specificity of the immunoreactivity
representative sections were processed in the same way
as described above using non-immune rabbit or mouse
sera instead of the primary antibodies, omitting the
primary antibodies in the incubation, or using pre-
absorbed antibodies for ASIC2 and TRPV4 (5 µg of the
blocking peptide in 1 ml of the antibody working
solution). 
Quantitative study
The density of nerve profiles within the whole
pharynx walls, excluding the mucosa, was determined
by evaluating the immunoreactive area for S100P and
NSE , ASIC2 and TRPV4 in 10 randomly selected fields
in 10 sections 200 μm apart using an automatic image
analysis system (Quantimet 550, Leika, QWIN Program;
Image Analysis Department, University of Oviedo). The
evaluation was carried out in duplicate by two
independent researchers. The density of nerve profiles
was determined using a x4 objective whereas the area
occupied by ASIC2 and TRPV4 within the corpuscles
was determined using a x20 objective. The values are
expressed as mean with standard deviation per 1 mm2.
4
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Fig. 2. Perivascular plexuses in pharynx controls (a) and OSAS patients (b-e) were evidenced using an antibody against the general neuronal marker




Statistical differences among groups were analyzed
using the Kruskall-Wallis test, and a p<0.05 was
considered significant. 
Results
To identify nerves within the pharyngeal walls we
used immunohistochemistry with specific markers for
axons and Schwann cells. Nerve profiles were found in
all the layers of the pharynx in both control subjects and
OSAS patients. Generally, the density of nerve profiles
identified was higher with anti-S100 protein antibodies
than with anti-NSE antibodies, and higher in the
oropharynx than hypopharynx (Table 3; Mu and
Sanders, 2000). 
Distribution of nerves and sensory corpuscles in the
pharynx
The nerves localized in the submucosa, forming
perivascular plexuses, or within the muscular layer were
quantified automatically; those localized in the
pharyngeal adventitia were evaluated only qualitatively.
The identification of sensory corpuscles was based on
morphological and immunohistochemical criteria, as
well as the arrangement of the constituent cells (see
Vega et al., 2009). 
In control subjects, nerves were observed below the
epithelium in close proximity to the basal layer, forming
small nerve bundles or dense vascular nerve plexuses
(Figs. 1a, 2a). No intraepithelial nerve fibers were found.
Within the muscular layer numerous corpuscle-like
nerve formations were observed, with a variable pattern
of arrangement of axons and Schwann-like cells, and
cannot be described following pre-established
morphological criteria. They were spiral-wharves shape
sensory formations, oval or elongated in shape, Ruffini-
like and Meissner-like corpuscles, and tree-like
corpuscles (Fig. 3; De Carlos et al., 2013). Most of them
were capsulated and supplied by a single axon, branched
and showing a very complex arrangement. Double
immunostaining confirmed these observations (Fig. 4).
Finally, Pacini-like corpuscles were occasionally found
in the adventitia and the connective tissue forming the
pharyngeal raphe (data not shown). 
The pattern described above did not vary
qualitatively in the pharynx of OSAS patients, but the
density of those structures was clearly reduced. 
The innervation of the pharynx is not age- or gender-
related.- Gender (higher prevalence in men than in
women) and age are two factors to be considered in the
pathogenesis of OSAS. In our studies, no gender-related
5
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Fig. 3. Different morphotypes of sensory corpuscles in the walls of the human pharynx in control (a, c-e) and OSAS (b, f-h) subjects. Spiral-wharves
nerve structures were regularly found in both groups of subjects (a and b). All the sensory nerve formations identified consisted of axons and Schwann
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Fig. 4. Sensory formations, or corpuscles from the human pharynx labeled with anti-S100 protein antibody conjugated with Alexa fluor 488 (green
fluorescence), and with anti-NSE antibody conjugated with CyTM3 (red fluorescence). The images show the relation between axons and Schwann-
related cells in these sensory structures.
Table 4. Correlation between age and density of NSE-positive nerve




<40 y 2,8±0,5 (n=2) 
40-50 y 3,0±0,9 (n=1) 1,6±0,9 (n=1)a
50-60 y 3,0±0,8 (n=4) 1,1±0,7 (n=2) 
>60 y 1,3±0,8 (n=7)a
Muscular layer 
<40 y 5,3±1,1 (n=2) 
40-50 y 5,5±0,9 (n=1) 3,7±0,8 (n=1)a
50-60 y 5,3±0,8 (n=4) 3,1±0,4 (n=2)a
>60 y 2,9±0,3 (n=7) 
Hypopharynx
Submucosa 
< 40 y 2,7±0,3 (n=2) 
40-50 y 2,9±0,5 (n=1) 1,3±0,3 (n=1)a
50-60 y 2,9±0,2 (n=4) 0,9±0,2 (n=2)b
>60 y 0,9±0,3 (n=7) 
Muscular layer 
< 40 y 5,1±1,2 (n=2) 
40-50 y 4,8±0,7 (n=1) 3,0±0,3 (n=1)a
50-60 y 5,0±0,9 (n=4) 3,3±0,2 (n=2)a
>60 y 2,9±0,6 (n=7) 
Results are expressed as the percentage of immunoreactive area
(mean ± SD) per mm2. a, p<0,05 vs control of the some age-group.
Table 3. Area occupied by nerve profiles displaying immunoreactivity for
the assessed antigens in the lateral wall of the pharynx of controls and
OSAS subjects.
Controls OSAS patients 
Female Male Female Male 
Oropharynx
Submucosa
S100P 3,7±0,6 3,3±0,4 1,2±0,8a 1,4±0,9a
NSE 2,9±0,5 2,5±0,3 0,8±0,2b 0,7±0,3b
ASIC2 nd nd nd nd
TRPV4 nd nd nd nd 
Muscular layer 
S100P 6,3±1,6 6,5±0,9 4,2±0,8a 4,4±1,0a
NSE 5,7±0,8 5,5±0,6 3,7±0,2a 3,9±0,6a
ASIC2 1,3±0,1 1,1±0,1 0,4±0,1a 0,5±0,1a
TRPV4 1,1±0,1 1,1±0,2 0,7±0,1a 0,7±0,1a
Hypopharynx
Submucosa
S100P 3,3±0,8 3,6±0,6 1,8±0,2a 1,6±0,8b
NSE 3,0±0,4 2,8±0,6 1,2±0,4b 1,0±0,8b
ASIC2 nd nd nd nd
TRPV4 nd nd nd nd
Muscular layer 
S100P 6,0±0,7 5,2±0,9 3,4±0,6a 3,4±0,9a
NSE 4,9±0,6 4,8±0,3 2,8±0,4a 2,9±0,8a
ASIC2 0,9±0,1 1,1±0,1 1,0±0,1 0,9±0,1
TRPV4 0,8±0,1 1,0±0,1 1,2±0,4 0,9±0,1
Results are expressed as the percentage of immunoreactive area
(mean ± SD) per 1 mm2. nd, not detectable. a, p<0,05 vs. the same




differences were observed in the innervation of the
oropharynx or the hypopharynx wall layers in control
subjects (Table 3). Regarding age, the density of nerves
in the pharyngeal layers was similar in control subjects
for the range studied (Table 4). 
The innervation of the pharynx is reduced in OSAS
patients.- After demonstrating that the density of nerves
in the pharynx remains constant with age and was
independent of gender in normal subjects, the next step
of our research was to determine whether or not the
pattern of innervation and nerve density is affected in
OSAS. Interestingly, the results were rather
homogeneous, and as occurred with control subjects, no
age-related or gender-related changes were observed in
patients with OSAS (Tables 3, 4). 
The density of nerve profiles observed in the
submucosa of OSAS patients was significantly reduced
compared with controls (Fig. 1b-f; Table 3). There was a
significant reduction of the submucous nerves and most
of the perivascular plexuses were missing or severely
reduced. In some cases (3/10) the epithelium of the
oropharynx contained a large number of S100 protein
positive cells, which, based on their morphology and
localization, were identified as Langerhans cells (see De
Melo et al., 2006). Of particular interest was the
reduction of the perivascular plexuses, which in some
cases were completely absent (Fig. 2a-e). 
Overall, there was a significant reduction in the
innervation density of the muscular layer in OSAS
compared with controls, while within the OSAS group
no age-related or gender-related changes were detected
(Fig. 5; Tables 3, 4). Regarding sensory corpuscles, all
the morphotypes found in controls were encountered in
OSAS patients, but most of them were smaller and
showed a hypothrophic or atrophic aspect (Figs. 3b,f-h,
4c,d). 
ASIC2 and to a lesser extent TRPV4 are severely
reduced in patients with OSAS
ASIC2 and TRPV4 are two putative
mechanoproteins localized in the axon of sensory
corpuscles (Del Valle et al., 2012) including those of the
human pharynx (De Carlos et al., 2013). The localization
7
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of ASIC2 and TRPV4 was investigated using
immunofluorescence and double immunohistochemistry
combined with axonic or Schwann cell markers. In
control subjects immunoreactity for ASIC2 and TRPV4
was observed in the axons of mechanosensory
corpuscles distributed throughout the muscular layer in
the control subjects (Fig. 6a,b); these structures were
never or only at residual levels detected in OSAS
patients (Fig. 6c-e). On the other hand, co-localization of
both ASIC2 and TRPV4 in the axons strongly supports
the mechanosensory function of these formations. 
Discussion
The goal of these studies was to investigate the
pattern and density of innervation in the human pharynx
of patients suffering OSAS. We quantified the density of
nerve profiles in the submucosa and muscular layers
(mainly formed by the superior constrictor pharyngeal
muscle, SCPM), the perivascular, and describe the
morphology and mechanoprotein-content of pharyngeal
sensory corpuscles as a means to test the neurogenic
origin paradigm of OSAS (Guilleminault et al., 2005;
Guillaumet and Ramar, 2009; Lévy et al., 2012). 
We have not been able to detect the presence of
intraepithelial nerve fibres, neither in control nor in
OSAS subjects, as reported in other species, but the
pattern of nerve distribution in the submucosa and
perivascular plexuses is in agreement with previous
studies (see for a review and references De Carlos et al.,
2013). Recently, we have described the mechanosensory
innervation pattern in the human pharynx (De Carlos et
al., 2013). Those findings are consistent with the results
reported here in control subjects. Furthermore, our
findings also demonstrated that there are no age- or
gender-related differences in the pattern of innervation
of the pharynx within the range analysed. 
The collapse of UA during sleep is the hallmark of
OSAS (see Eckert and Malhotra, 2008). Two theories
have been proposed to explain the pathophysiology of
OSAS: the obstructive theory, which postulates that
muscle hypertrophy leads to airway narrowing; and the
neurogenic theory, which postulates peripheral nerve
degeneration due to vibratory stretch trauma, or systemic
8
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Fig. 6. Immunohistochemical detection of ASIC2 (a) and TRPV4 (b) in different kinds of mechanoreceptors in the walls of the human pharynx in control
subjects (a, b) and OSAS patients (c, d). Co-localization studies demonstrate that ASIC2 and TRPV4 (green fluorescence) are primarily found in the




diseases, leads to muscle atrophy and collapse (see
Saboisky et al., 2012a; Tsai et al., 2013). 
In patients with OSAS there are changes in
sensation, muscle properties, and neural tone in the UA;
these changes are referred to as airway remodeling. But
whereas the muscle fibers, motor nerve fibers and motor
endplates of OSAS patients have been studied in depth
(Lindman and Stal, 2002; Boyd et al., 2004; Stål et al.,
2009; Saboisky et al., 2012a), the potential role of
sensory nerve impairment in OSAS has not been
sufficiently investigated (Kimoff et al., 2001; Nguyen et
al., 2005). 
We believe that if UA motor axons, anatomically
deeper, are affected by vibration, the sensory afferents,
closer to the airway surface, should also be impaired. In
this study we demonstrate abnormal sensory innervation
of the pharynx that can result in diminished reflexogenic
dilation of UA mediated by afferents in the pharyngeal
mucosa. Our results demonstrate a significant reduction
in the density of nerve fibers in the submucosa, muscular
layer and perivascular plexuses in OSAS patients, as
well as abnormal mechanosensory corpuscles in the
muscular layer, which all together support to the
neurogenic theory of OSAS. These data are consistent
with findings by Bassiouny et al. (2009) and De Bellis et
al. (2012) in the human uvula of apneic snorers, but
differs from studies of others that have found increased
numbers of nerve fibers in the mucosa and muscles
(Friberg et al., 1997; Boyd et al., 2004). Importantly,
since the markers used are not specific for motor nerve
fibers of motor endplates we cannot support motor
impairment, although, as a whole, the innervation of the
muscular layer was found to be reduced in OSAS. 
Regarding mechanosensory corpuscles in the
muscular layer, the primary goal of those studies, they
were readily detectable in OSAS patients, but they were
disarranged and smaller than in control subjects.
Furthermore, there was an almost complete loss of
ASIC2 and TRPV4 in the mechanoreceptors of OSAS
subjects. Overall, these findings suggest that patients
with OSAS have impaired pharyngeal sensitivity and
mechanosensation. The proprioception arising from
pharyngeal muscles is important in the physiology of the
UA for regulation of important reflexes related to normal
breathing (see for a review Miller, 2002). Interestingly,
patients with OSAS have altered vibration and cold
detection thresholds (Larsson et al., 1992; Hagander et
al., 2009). 
Some limitations of the present study were the small
number of subjects and that the biopsies were obtained
from a limited area of the AU that may not be
representative of the whole organ. It is likely that the
absence of age-related and gender-related changes in
OSAS patients is related to the small number of subjects
included in the study (Eikermann et al., 2007; Ralls and
Grigg-Damberger, 2012). Further studies are now in
progress in our laboratory sampling larger areas of the
palatum and pharynx in order to confirm whether the
changes in innervation reported here involve the whole UA. 
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